Are There Biomarkers Related to MRE11 for Prognosis and Treatment?
MRE11 expression and mutation status could serve as potential biomarkers for predicting cancer prognosis and treatment response. High levels of MRE11 expression have been linked to poor outcomes in certain cancers, while its deficiency might indicate sensitivity to DNA-damaging treatments. Further research is needed to validate MRE11-related biomarkers and integrate them into clinical practice for personalized cancer therapy.
